Objective

• Evaluate drugs in cancer cells isolated from fresh cancer tissue to:
• Screen new chemical or biological entities for companies
• Generate Indian cancer patient response data by combining in vitro assays with outcomes
• Systematically screen Indian cancers against a ‘pill box’
• Can repurpose drugs / combinations to benefit patients
• Conduct gene profiling of Indian cancers

ADVANTAGE !!!

Our platforms mimic clinical variability in terms of:
1. Genetic diversity
2. Distinguish between driver & passenger mutations
3. Disease state based variations
4. Early passages – more closer to disease phenotype
5. Treatment naive samples
6. Appropriate normal tissue controls